Russell A S, Hui B K
562 Heritage Medical Research Centre, University of Alberta Hospital, Edmonton, Alberta, Canada T6G 2S2.
Rheumatol Int. 2005 May;25(4):292-5. doi: 10.1007/s00296-004-0548-8. Epub 2004 Dec 10.
To determine whether the Primary Care Evaluation of Mental Disorders 1-page Brief Patient Health Questionnaire (PRIME-MD 1-page PHQ) can serve as: (1) a diagnostic test for fibromyalgia syndrome (FM), or (2) a questionnaire through which internists can be alerted to otherwise hidden mental disorders in patients attending internal medicine clinics.
Two hundred and thirteen consecutive patients attending a rheumatology clinic were given the PRIME-MD 1-page PHQ and seen by a rheumatologist who was blind to the PRIME-MD diagnosis.
The PRIME-MD 1-page PHQ pointed to Major Depressive Disorder in 33.3% of FM patients, Other Depressive Disorder in 33.3% of FM patients, and Panic Disorder in 22.2% of FM patients (all of whom also had Major Depressive Disorder), as compared to 13.1, 13.1, and 3.0% respectively in patients with other rheumatic disorders. However, when used as a diagnostic test for FM, the PRIME-MD 1-page PHQ did not have adequate diagnostic value. When all the PRIME-MD 1-page PHQ diagnoses were compiled, however, a trend was observed. Compared to the rates of mental disorders in both the normal population and in primary care practices, the rates found in this rheumatology clinic were higher.
The PRIME-MD 1-page PHQ is not an adequate diagnostic test for FM. Because FM is primarily a somatization disorder that draws its symptoms from other current diseases, it may in fact be impossible to diagnose FM based on specific symptoms alone. However, the PRIME-MD 1-page PHQ proved to be a useful diagnostic tool in a rheumatology clinic. It helped to alert the physician to the possibility of an elevated frequency of mental disorders that would otherwise have gone unnoticed and untreated.
确定简明精神障碍初级保健评估单页患者健康问卷(PRIME-MD 1页PHQ)是否可作为:(1)纤维肌痛综合征(FM)的诊断测试,或(2)一种问卷,通过它内科医生能够注意到在内科门诊就诊患者中原本隐藏的精神障碍。
连续213名在风湿病门诊就诊的患者接受了PRIME-MD 1页PHQ测试,并由一位对PRIME-MD诊断不知情的风湿病医生进行检查。
PRIME-MD 1页PHQ显示,33.3%的FM患者存在重度抑郁症,33.3%的FM患者存在其他抑郁症,22.2%的FM患者存在惊恐障碍(所有这些患者也患有重度抑郁症),相比之下,其他风湿性疾病患者中的比例分别为13.1%、13.1%和3.0%。然而,当用作FM的诊断测试时,PRIME-MD 1页PHQ没有足够的诊断价值。不过,当汇总所有PRIME-MD 1页PHQ诊断结果时,观察到一种趋势。与正常人群和初级保健机构中的精神障碍发生率相比,该风湿病门诊的发生率更高。
PRIME-MD 1页PHQ不是FM的充分诊断测试。由于FM主要是一种躯体化障碍,其症状源于其他当前疾病,实际上仅根据特定症状可能无法诊断FM。然而,PRIME-MD 1页PHQ在风湿病门诊被证明是一种有用的诊断工具。它有助于提醒医生注意精神障碍发生率升高的可能性,否则这些情况可能会被忽视和未得到治疗。